YOSITAN

WIPO WIPO 2008

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark YOSITAN was filed as Word mark on 12/23/2008 at the World Intellectual Property Organization.

Trademark Details Last update: July 16, 2019

Trademark form Word mark
File reference 991762
Countries Australia Switzerland China Japan Norway United States of America (USA)
Base trademark EU No. 007037039, July 4, 2008
Application date December 23, 2008
Expiration date December 23, 2018

Trademark owner

Lochhamer Str. 11
82152 Planegg, Martinsried
DE

Trademark representatives

Josephspitalstr. 15 80331 Munich DE

goods and services

05 Pharmaceutical and veterinary preparations for the prevention, treatment and/or diagnosis of diseases, in particular medicines, vaccines, serums and/or test kits for the prevention, treatment and/or diagnosis of tumour precursors, benign and malignant tumours, in particular warts, genital warts, neuronal tumours, glioma, astrocytoma, colon carcinoma, ovarian carcinoma, cervical cancer, prostate carcinoma, basal cell carcinoma, squamous cell carcinoma, melanoma, Kaposi's sarcoma, breast cancer, head and neck carcinomas, hepatocellular carcinoma, bronchial carcinoma, pancreatic tumours and/or renal tumours, autoimmune disorders, in particular rheumatoid arthritis, polyarthritis, Crohn's disease, lupus erythematosus and/or multiple sclerosis, neurodegenerative disorders, in particular Alzheimer's disease, Huntington's disease, multiple sclerosis, Parkinson's disease, schizophrenia, transmissible spongiform encephalopathy, bovine spongiform encephalopathy and/or Creutzfeldt-Jakob disease, rheumatic disorders, in particular rheumatoid arthritis, polychondritis, Bechterew's disease, fibromyalgia and/or lupus erythematosus, allergic diseases, in particular allergies, allergic rhinitis, hay fever, asthma, atopic eczema and/or insect sting allergies, cardiovascular disorders, in particular hyperlipidaemia, coronary artery disorders, cardiac insufficiency, high blood pressure and/or obesity, skin diseases, in particular warts, genital warts, Bowen's disease, actinic keratosis, seborrhoeic keratosis, psoriasis, dermatitis, eczema, acne, rosacea and/or herpes, infectious diseases, in particular viral infections, bacterial infections, parasitic infections and/or fungal infections and/or ophthalmic disorders, in particular age-dependent macular degeneration, glaucoma and/or retinoblastoma, in particular low-molecular active substances, liposomes, aptamers, nucleic acids, peptides, proteins, protein, conjugates, antibodies, T-cell proteins, enzymes and enzyme preparations, hormones, hormone analogues, attenuated viruses, virus-type particles and/or plant extracts, in particular for oral, topical, intravenous and/or subcutaneous administration

Trademark history

Date Document number Area Entry
July 6, 2019 2019/27 Gaz Deletion
June 16, 2017 US RAW: Total Invalidation
June 24, 2010 2010/26 Gaz JP RAW: Rule 18ter(2)(i) GP following a provisional refusal
June 14, 2010 2013/3 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
October 15, 2009 2009/43 Gaz JP Rejection
August 3, 2009 2009/34 Gaz NO RAW: Protection Granted
June 30, 2009 2009/27 Gaz AU RAW: Protection Granted
March 25, 2009 2009/14 Gaz US Rejection
December 23, 2008 2009/6 Gaz EM Registration

ID: 14991762